Resveratrol Science Hits a Wall

An in-depth analysis shows the red-wine chemical has medical potential but is no fountain of youth
Apr 1, 2011

Editor's Note: In early 2012, the University of Connecticut announced that a three-year investigation of Professor Dipak Das found extensive evidence he had falsified data in certain studies. It is unclear yet which of Das' studies are compromised, but his findings on wine and polyphenols are now under question.

A leading researcher’s review of more than a hundred studies of resveratrol, the red-wine compound that has spurred millions of dollars of investment by pharmaceutical and nutritional companies, raises more questions than it answers. According to the study, there is substantial evidence that resveratrol can lower the risk of deadly diseases, such as diabetes, heart failure and some types of cancer. But it seems to offer little help at extending lifespan.

Early research found evidence that resveratrol might slow aging on a cellular level. Numerous nutritional supplement companies still tout this when marketing various resveratrol products.

But Dipak Das, a researcher at the University of Connecticut’s Cardiovascular Research Center, reviewed more than 100 studies on resveratrol and said there is no scientific basis for that conclusion. The meta-analysis, titled "Erratum to: Resveratrol and red wine, healthy heart and longevity," refers to the emerging doubts of resveratrol as an anti-aging compound. It is slated for publication in Heart Failure Reviews.

In early studies, resveratrol was linked to extending the lifespans of fruit flies and tropical killifish. But once the studies moved on to mammals, scientists found that while disease rates still declined with the consumption of resveratrol, the animals didn’t live longer.

The conclusions are puzzling, Das said, because it appears that resveratrol should be able to increase the length of life—researchers found the chemical manipulates genes and increases longevity on the cellular level. "Resveratrol is so powerful it can activate stem-cell survival," Das said. "So why is it not extending lifespan, by improving the survivability of genes?"

Das said his research shows the limitation of modern science to deeply delve into the issue. For one, real longevity research on humans should involve humans, he said, and should last for decades. "If you want answers to the longevity of mammals, it will take years and years of dedication," he said. "Right now, we can only offer a snapshot and that isn't powerful enough."

There’s another practical reason, one that involves funding and career paths. A top resveratrol researcher from Harvard, David Sinclair, found a few years ago that resveratrol may mimic the effect of caloric restriction in humans. This is the only known way to extend life, Das writes in his study. Not to be confused with starvation, which increases metabolism and therefore hastens death, caloric restriction involves controlled limited calorie intake. (It appears to activate a genetic response that extends life when food is scarce, allowing animals to survive until supplies improve and they can reproduce.)

But most research dollars—both public and private—don’t go to studies focused on abstract concepts like anti-aging. The money goes to fight specific illnesses. Armed with evidence that resveratrol lowered the risk of Type-2 diabetes, Sinclair opened Sirtris Pharmaceuticals in an effort to develop drugs based on resveratrol that could treat various diseases.

GlaxoSmithKline soon purchased the company and began trials with several synthetic variants of the polyphenol. Glaxo would later halt one study focused on a resveratrol variant that led to complications. Competitors Pfizer and Amgens also experienced setbacks and could not verify Sinclair's earlier resveratrol results in subsequent lab tests, the study states.

On the anti-aging front, no one else stepped in to fill Sinclair's shoes. "For some reason we all stopped looking into [the anti-aging aspect] after Sinclair's study came out three years ago," Das said.

What Das’ work illustrates is that resveratrol still holds many mysteries. It appears that science is still at the starting line.

Health Resveratrol News

You Might Also Like

White House Spares European Wines from 100 Percent Tariffs for Now; 25 Percent Duties Remain in Place

White House Spares European Wines from 100 Percent Tariffs for Now; 25 Percent Duties Remain in Place

After reviewing the tariffs in the Airbus fight, the U.S. Trade Rep has raised duties on …

Feb 14, 2020
A New Chapter for Grand Award Winner Addison in San Diego

A New Chapter for Grand Award Winner Addison in San Diego

The restaurant sports a newly appointed wine director and a redesigned dining room. Plus, …

Feb 13, 2020
Robert Mondavi Winery Sits in the To Kalon Vineyard. Its Owner Says There's No Such Place

Robert Mondavi Winery Sits in the To Kalon Vineyard. Its Owner Says There's No Such Place

Is To Kalon a vineyard or a brand? Constellation is fighting neighbors who want to put it …

Feb 13, 2020
Spain Shines at the First Barcelona Wine Week

Spain Shines at the First Barcelona Wine Week

Hundreds of the country's best wineries came together for an ambitious new trade show

Feb 11, 2020
French Winemakers Feel the Tariff Pain

French Winemakers Feel the Tariff Pain

While U.S. wine merchants lobby to stop 100 percent tariffs on European wines, French …

Feb 10, 2020
Is Chablis Part of Burgundy? What About Beaujolais?

Is Chablis Part of Burgundy? What About Beaujolais?

A debate over appellations has some vintners angry, leading French officials to back down …

Feb 7, 2020
WineRatings+

WineRatings+

Xvalues

Xvalues

Restaurant Search

Restaurant Search